Shares of Eli Lilly & Co. erased gains to trade down nearly 1% after White House press secretary Karoline Leavitt said the company was among 17 drugmakers that will be receiving letters from ...

FACT FOCUS: Trump says he's cut drug prices by up to 1,500%. That's not possible Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing ...

At AAIC, Lilly highlighted benefits of being able to stop Kisunla, while Eisai made a case for subcutaneous Leqembi, which is awaiting approval for maintenance dosing.

Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year ...

Patients taking the GLP-1 weight loss drug Zepbound face mandatory switch to Wegovy after CVS Caremark removed the Eli Lilly medication from its preferred coverage list, citing rising costs.

Eli Lilly & Company (NYSE:LLY) is a major global pharmaceutical company that develops, manufactures, and distributes a wide range of drugs. Founded in 1876, it has grown to become one of the world ...

Eli Lilly on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use, which previously recommended against approval of Kisunla, is now backing the drug for use ...

Eli Lilly has cleared a major hurdle in its bid to win European approval for its Alzheimer's disease drug Kisunla. Eli Lilly on Friday said the European Medicines Agency's Committee for Medicinal ...

UPenn sues Eli Lilly, CVS Caremark, others over insulin price scheme There are hundreds of pending lawsuits against the drug companies and PBMs over insulin prices. People with diabetes use insulin to ...

Eli Lilly LLY offers a diverse range of products that serve multiple therapeutic areas. While the company’s primary focus is on diabetes and obesity drugs, the oncology franchise also remains a ...

Eli Lilly's shares are priced for perfection. The forward price-to-earnings ratio was recently 35.5; the average for the healthcare sector is less than half that at 16.